This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: University of California. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Lee E Dunlap: Innovator in Brain Disorder Treatments
Introduction
Lee E Dunlap is a prominent inventor based in Oakland, CA (US). He has made significant contributions to the field of neuroscience through his innovative research and development of compounds aimed at treating brain disorders. With a total of 2 patents, Dunlap's work focuses on enhancing neural plasticity and dendritic spine density.
Latest Patents
Dunlap's latest patents include groundbreaking inventions such as "Tetracyclic compounds for treating brain disorders." This patent provides tetracyclic heterocyclic compounds that can be useful for methods of treating diseases or for increasing neural plasticity. Additionally, he has developed "N-substituted indoles and other heterocycles for treating brain disorders," which outlines methods of using these compounds for therapeutic purposes.
Career Highlights
Dunlap is affiliated with the University of California, where he continues to advance his research in the field of neuroscience. His work has garnered attention for its potential impact on treating various brain disorders, showcasing his dedication to improving mental health.
Collaborations
Some of his notable coworkers include David E Olson and Florence Wagner, who have collaborated with him on various research projects aimed at enhancing the understanding and treatment of brain disorders.
Conclusion
Lee E Dunlap's innovative contributions to neuroscience through his patents and research at the University of California highlight his commitment to advancing treatments for brain disorders. His work continues to inspire future developments in the field.